We describe here a genome-wide short hairpin RNA (shRNA) loss-of-function genetic screen to identify genes whose suppression can confer sensitivity to crizotinib in ALK+ NSCLC lines. The gene discussed is ALK; the disease is non-small cell lung carcinoma.